Cargando…
Contribution of Epithelial Plasticity to Therapy Resistance
Therapy resistance is responsible for tumour recurrence and represents one of the major challenges in present oncology. Significant advances have been made in the understanding of the mechanisms underlying resistance to conventional and targeted therapies improving the clinical management of relapse...
Autores principales: | Santamaría, Patricia G., Moreno-Bueno, Gema, Cano, Amparo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571660/ https://www.ncbi.nlm.nih.gov/pubmed/31091749 http://dx.doi.org/10.3390/jcm8050676 |
Ejemplares similares
-
EMT: Present and future in clinical oncology
por: Santamaria, Patricia G., et al.
Publicado: (2017) -
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives
por: Díaz-López, Antonio, et al.
Publicado: (2014) -
Loxl3 Promotes Melanoma Progression and Dissemination Influencing Cell Plasticity and Survival
por: Vázquez-Naharro, Alberto, et al.
Publicado: (2022) -
LOXL2 catalytically inactive mutants mediate epithelial-to-mesenchymal transition
por: Cuevas, Eva P., et al.
Publicado: (2014) -
E2A Modulates Stemness, Metastasis, and Therapeutic Resistance of Breast Cancer
por: López-Menéndez, Celia, et al.
Publicado: (2021)